Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $1.234B (100.0% shares, 0.0% debt)

Holdings (22)

EWTX EDGEWISE THERAPEUTICS INC 13.7%

Value $169M Shares 5,350,000 Share Price $31.50 * Est. Cost/Share $18.02 Unrealized @ Report Date +56.4%

BN BROOKFIELD CORP 11.5%

Value $141M Shares 3,496,245 Share Price $40.47 * Est. Cost/Share $29.96 Unrealized @ Report Date +55.8%

ASML ASML HOLDING N V 10.2%

Value $125M Shares 94,946 Share Price $1320.83 Est. Cost/Share $662.32 Unrealized @ Report Date —

MIRM MIRUM PHARMACEUTICALS INC 9.9%

Value $122M Shares 1,325,000 Share Price $92.38 * Est. Cost/Share $16.14 Unrealized @ Report Date +498.1%

MPLT MAPLIGHT THERAPEUTICS INC 6.1%

Value $74.95M Shares 3,686,622 Share Price $20.33 * Est. Cost/Share $16.75 Unrealized @ Report Date +5.2%

CRM SALESFORCE INC 5.9%

Value $73.4M Shares 393,187 Share Price $186.67 * Est. Cost/Share $207.33 Unrealized @ Report Date +4.1%

CRNX CRINETICS PHARMACEUTICALS IN 4.6%

Value $56.3M Shares 1,550,000 Share Price $36.32 * Est. Cost/Share $25.38 Unrealized @ Report Date +93.9%

ELVN ENLIVEN THERAPEUTICS INC 4.1%

Value $50.18M Shares 1,280,000 Share Price $39.20 * Est. Cost/Share $19.25 Unrealized @ Report Date +33.0%

PCVX VAXCYTE INC 4.0%

Value $49.97M Shares 860,000 Share Price $58.11 * Est. Cost/Share $39.88 Unrealized @ Report Date +32.3%

PHVS PHARVARIS N V 4.0%

Value $49.44M Shares 1,750,000 Share Price $28.25 * Est. Cost/Share $15.36 Unrealized @ Report Date +74.1%

AVBP ARRIVENT BIOPHARMA INC 3.6%

Value $44.81M Shares 1,942,142 Share Price $23.07 * Est. Cost/Share $20.49 Unrealized @ Report Date +7.7%

VRDN VIRIDIAN THERAPEUTICS INC 3.2%

Value $39.12M Shares 2,000,000 Share Price $19.56 * Est. Cost/Share $16.63 Unrealized @ Report Date +85.5%

CLDX CELLDEX THERAPEUTICS INC NEW 3.1%

Value $38.06M Shares 1,200,000 Share Price $31.72 * Est. Cost/Share $34.88 Unrealized @ Report Date -27.1%

APGE APOGEE THERAPEUTICS INC 3.1%

Value $37.88M Shares 450,000 Share Price $84.17 * Est. Cost/Share $41.12 Unrealized @ Report Date +75.7%

BMRN BIOMARIN PHARMACEUTICAL INC 3.0%

Value $37.28M Shares 660,000 Share Price $56.49 * Est. Cost/Share $77.70 Unrealized @ Report Date -24.4%

FDMT 4D MOLECULAR THERAPEUTICS IN 2.8%

Value $33.99M Shares 3,650,737 Share Price $9.31 * Est. Cost/Share $12.43 Unrealized @ Report Date -31.0%

BABA ALIBABA GROUP HLDG LTD 2.6%

Value $32.28M Shares 257,327 Share Price $125.46 Est. Cost/Share $165.09 Unrealized @ Report Date —

XENE XENON PHARMACEUTICALS INC 2.3%

Value $28.23M Shares 485,438 Share Price $58.15 * Est. Cost/Share $41.98 Unrealized @ Report Date 0.0%

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 1.6%

Value $19.56M Shares 2,185,923 Share Price $8.95 Est. Cost/Share $11.31 Unrealized @ Report Date —

VALN VALNEVA SE 0.5%

Value $6.609M Shares 1,057,421 Share Price $6.25 Est. Cost/Share $5.67 Unrealized @ Report Date —

LNZA LANZATECH GLOBAL INC 0.2%

Value $2.532M Shares 158,148 Share Price $16.01 * Est. Cost/Share $28.70 Unrealized @ Report Date -58.8%

MQ MARQETA INC 0.1%

Value $1.802M Shares 441,558 Share Price $4.08 * Est. Cost/Share $22.37 Unrealized @ Report Date -80.7%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
EWTX	EDGEWISE THERAPEUTICS INC	5,350,000	$169M	13.7%	$31.50 *	$18.02	+56.4%	COM	28036F105
BN	BROOKFIELD CORP	3,496,245	$141M	11.5%	$40.47 *	$29.96	+55.8%	CL A LTD VT SH	11271J107
ASML	ASML HOLDING N V	94,946	$125M	10.2%	$1320.83	$662.32	—	N Y REGISTRY SHS	N07059210
MIRM	MIRUM PHARMACEUTICALS INC	1,325,000	$122M	9.9%	$92.38 *	$16.14	+498.1%	COM	604749101
MPLT	MAPLIGHT THERAPEUTICS INC	3,686,622	$74.95M	6.1%	$20.33 *	$16.75	+5.2%	COM	56565P103
CRM	SALESFORCE INC	393,187	$73.4M	5.9%	$186.67 *	$207.33	+4.1%	COM	79466L302
CRNX	CRINETICS PHARMACEUTICALS IN	1,550,000	$56.3M	4.6%	$36.32 *	$25.38	+93.9%	COM	22663K107
ELVN	ENLIVEN THERAPEUTICS INC	1,280,000	$50.18M	4.1%	$39.20 *	$19.25	+33.0%	COM	29337E102
PCVX	VAXCYTE INC	860,000	$49.97M	4.0%	$58.11 *	$39.88	+32.3%	COM	92243G108
PHVS	PHARVARIS N V	1,750,000	$49.44M	4.0%	$28.25 *	$15.36	+74.1%	COM	N69605108
AVBP	ARRIVENT BIOPHARMA INC	1,942,142	$44.81M	3.6%	$23.07 *	$20.49	+7.7%	COM	04272N102
VRDN	VIRIDIAN THERAPEUTICS INC	2,000,000	$39.12M	3.2%	$19.56 *	$16.63	+85.5%	COM	92790C104
CLDX	CELLDEX THERAPEUTICS INC NEW	1,200,000	$38.06M	3.1%	$31.72 *	$34.88	-27.1%	COM NEW	15117B202
APGE	APOGEE THERAPEUTICS INC	450,000	$37.88M	3.1%	$84.17 *	$41.12	+75.7%	COM	03770N101
BMRN	BIOMARIN PHARMACEUTICAL INC	660,000	$37.28M	3.0%	$56.49 *	$77.70	-24.4%	COM	09061G101
FDMT	4D MOLECULAR THERAPEUTICS IN	3,650,737	$33.99M	2.8%	$9.31 *	$12.43	-31.0%	COM	35104E100
BABA	ALIBABA GROUP HLDG LTD	257,327	$32.28M	2.6%	$125.46	$165.09	—	SPONSORED ADS	01609W102
XENE	XENON PHARMACEUTICALS INC	485,438	$28.23M	2.3%	$58.15 *	$41.98	0.0%	COM	98420N105
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	2,185,923	$19.56M	1.6%	$8.95	$11.31	—	COM NEW	107924102
VALN	VALNEVA SE	1,057,421	$6.609M	0.5%	$6.25	$5.67	—	SPONSORED ADS	92025Y103
LNZA	LANZATECH GLOBAL INC	158,148	$2.532M	0.2%	$16.01 *	$28.70	-58.8%	COM NEW	51655R200
MQ	MARQETA INC	441,558	$1.802M	0.1%	$4.08 *	$22.37	-80.7%	CLASS A COM	57142B104